Summary
A 8.5-month prospective study was performed in the Rhône area of France to study the incidence of infectious diseases in children in day care, and the qualitative and quantitative aspects of drug prescriptions for young children. The families of 1.359 children agreed to participate (98.5% of those selected).
During the follow-up period 3.605 infections episodes were reported and 10.706 medications were used, an average of 3.0 medications per episode. Antibiotics were used in the treatment of 2.333 infectious episodes (65%) amoxycillin (36%), cephalosporin (23%), macrolide (17%) and trimethoprim-sulphamethoxazole (9%). Acetylsalicylic acid and paracetamol were used 865- and 1.568-times, respectively. Drugs with multi-active components represented 11.3% of the total number of systemic medicines reported. Paracetamol was prescribed in 59% of cases in a multi-active component drug, whereas this type of product accounted for 83.5% of the antihistamines (used 932-times).
The rationale behind the paediatric prescribing habits of French medical doctors is discussed in relation to results previously obtained in other European countries.
References
Howie VM, Ploussard JH, Sloyer J (1975) The “otitis prone” condition. Am J Dis Child 129: 676–678
Teele DW, Klein JO, Rosner BA (1980) Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 89 [Suppl 68]: 5–6
Teele DW, Klein JO, Rosner BA (1983) Middle ear disease and the practice of pediatrics: burden during the first five years of life. JAMA 249: 1026–1029
Anderson HR, Bland JM, Patel S, Peckham CS (1986) The natural history of asthma in childhood. J Epidemiol Commun Health 40: 121–129
Horwood LJ, Fergusson DM, Shannon FT (1985) Social and familial factors in the development of early childhood asthma. Pediatrics 75: 859–868
Anderson R (1980) Prescribed medicines: Who takes what? J Epidemiol Commun Health 34: 299–304
Bergman U, Sjöqvist F (1984) Measurement of drug utilization in Sweden: Methodological and clinical implications. In: Drug utilization studies: Implications for medical care. Acta Med Scand 683 [Suppl]: 15–22
Catford J (1980) Quality of prescribing for children in general practice. Br Med J 1: 1435–1437
Fosarelli P, Wilson M, De Angelis C (1987) Prescription medication in infancy and early childhood. Am J Dis Child 141: 772–775
Kennedy D, Forbes M (1982) Drug therapy for ambulatory pediatric patients in 1979. Pediatrics 70: 26–29
Rylance G (1979) Prescribing in infancy and childhood. Br J Hosp Med 21: 346–351
Sanz EJ, Bergman U, Dahlström M (1989) Pediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur J Clin Pharmacol 37: 65–68
Sanz EJ, Boada J (1988) Drug utilization in pediatric out patient in Tenerife (Canary Islands). Eur J Clin Pharmacol 34: 495–499
Collet JP, Ducruet T, Floret D, Cogan-Collet J, Honneger D, Boissel JP (1991) Day care attendance and risk of first infectious disease. Eur J Pediatr 150: 214–216
Fleming DW, Cochi SL, Hightower AW, Broome CV (1987) Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatric 79: 55–60
Pickering LK, Woodward WE (1982) Diarrhea in day care centers. Pediatr Infect Dis 1: 47–52
Hurwitz ES, Gunn WJ, Pinsky PF, Schonberger LB (1991) Risk of respiratory illness associated with day-care attendance: a nationwide study. Pediatrics 87: 62–69
Kramer MS, Hutchinson TA, Naimark L, Contardi R, Flegel KM, Leduc DG (1985) Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. Pediatrics 76: 365–370
Martindale. The Extra Pharmacopoeia, 28th Edition (1982) Ed JEF Reynolds. Pharmaceutical Press, London, pp 234–244
Author information
Authors and Affiliations
Consortia
Additional information
This work was supported by two grants from the Laboratories Fournier (Dijon-France) and the National Laboratory of Health in Lyon (affiliated to the WHO)
Rights and permissions
About this article
Cite this article
Collet, J.P., Bossard, N., Floret, D. et al. Drug prescription in young children: results of a survey in France. Eur J Clin Pharmacol 41, 489–491 (1991). https://doi.org/10.1007/BF00626376
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00626376